<DOC>
	<DOCNO>NCT00732511</DOCNO>
	<brief_summary>We compare blood pressure-lowering effect two marketed medication , Coreg CR Toprol XL . Although drug reduce blood pressure block action noradrenaline beta-receptors blood vessel , Coreg CR also block alpha-receptors , may provide add blood pressure-lowering . In addition , Coreg CR may anti-oxidant action . Cells line blood vessel ( term `` endothelial cell '' ) make nitric oxide ( NO ) , relaxes muscle cell encircle blood vessel , cause reduction blood pressure . When body cell use oxygen , normally produce `` free radical '' , destroy NO , lead high blood pressure , heart damage worsenimg diabetes . Antioxidants remove free radical prevent repair damage . In study measure endothelial cell function , blood vessel wall stiffness , NO exhale breath , blood level substance reflect NO production destruction determine pure beta-blocker ( Toprol XL ) differs alpha/beta blocker ( Coreg CR ) effect . We also examine mechanism difference might occur .</brief_summary>
	<brief_title>Coreg CR , Blood Vessel Stiffness Blood Vessel Function</brief_title>
	<detailed_description>The follow technique use : Endothelial function measure non-invasively flow-mediated change pulsatile blood volume finger-tips . Vascular compliance ( stiffness ) assess tonometry radial pulse wave ( `` augmentation index '' ) diastolic puse wave analysis . Plasma nitrate/nitrite level mirror NO production measure spectrophotometrically Griess reaction . Plasma nitrotyrosine , vivo marker NO-dependent damage induce reactive nitrogen intermediate derive NO , measure ELISA . Exhaled NO may provide real-time measure endothelial cell NO production measure hand-held device contains electrochemical detector sensitive 5 ppb .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>1 . Type 2 diabetes mellitus , 2 . Stable antidiabetic regimen 3 month 3 . Hemoglobin A1c &lt; 8.6 % 4 . Stable antihypertensive medication regimen 3 month , include either angiotensinconverting enzyme inhibitor angiotensin receptor blocker 1 . Any clinically significant abnormality history , physical examination , laboratory testing could preclude safe completion study 2 . Significant cardiac condition 3 . Lung disease 4 . Cigarette smoke 5 . Chronic kidney disease ( Stage 3 great ) 6 . Type 1 diabetes 7 . Known contraindication alpha betablocker therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Blood vessel stiffness</keyword>
	<keyword>Nitric oxide</keyword>
	<keyword>Oxidative stress</keyword>
</DOC>